Dimensional Fund Advisors LP Allogene Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,090,753 shares of ALLO stock, worth $2.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,090,753

Previous 2,736,419 23.6%

Holding current value

$2.57 Million

Previous $3.09 Million 16.17%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$1.03 - $1.66 $665,035 - $1.07 Million	-645,666 Reduced 23.6%	2,090,753 $2.59 Million
Q2 2025 Aug 12, 2025	SELL	$0.95 - $1.7 $421,262 - $753,837	-443,434 Reduced 13.95%	2,736,419 $3.09 Million
Q1 2025 May 13, 2025	SELL	$1.4 - $2.84 $534,482 - $1.08 Million	-381,773 Reduced 10.72%	3,179,853 $4.64 Million
Q4 2024 Feb 13, 2025	BUY	$1.84 - $3.22 $1.53 Million - $2.68 Million	831,146 Added 30.44%	3,561,626 $7.59 Million
Q3 2024 Nov 07, 2024	BUY	$2.08 - $3.5 $374,067 - $629,440	179,840 Added 7.05%	2,730,480 $7.65 Million

Q2 2024 Aug 09, 2024	BUY	$2.23 - $4.38 $1.13 Million - $2.22 Million	507,021 Added 24.81%	2,550,640 $5.94 Million
Q1 2024 May 10, 2024	BUY	$2.92 - $5.63 $1.48 Million - $2.86 Million	508,374 Added 33.11%	2,043,619 $9.13 Million
Q4 2023 Feb 07, 2024	SELL	$2.28 - $3.5 $691,093 - $1.06 Million	-303,111 Reduced 16.49%	1,535,245 $4.93 Million
Q3 2023 Nov 09, 2023	BUY	$3.17 - $5.96 $1.73 Million - $3.26 Million	546,215 Added 42.27%	1,838,356 $5.83 Million
Q2 2023 Aug 09, 2023	SELL	$4.53 - $6.74 $3.43 Million - $5.1 Million	-757,115 Reduced 36.95%	1,292,141 $6.42 Million
Q1 2023 May 12, 2023	SELL	$4.92 - $8.21 $1.68 Million - $2.8 Million	-340,848 Reduced 14.26%	2,049,256 $10.1 Million
Q4 2022 Feb 09, 2023	BUY	$5.62 - $11.11 $3.68 Million - $7.28 Million	655,317 Added 37.78%	2,390,104 $15 Million
Q3 2022 Nov 10, 2022	BUY	$10.32 - $17.28 $4.95 Million - $8.3 Million	480,099 Added 38.26%	1,734,787 $18.7 Million
Q2 2022 Aug 12, 2022	BUY	$6.78 - $12.28 $3.04 Million - $5.51 Million	448,701 Added 55.67%	1,254,688 $14.3 Million
Q1 2022 May 13, 2022	BUY	$7.65 - $15.29 $468,631 - $936,650	61,259 Added 8.23%	805,987 $7.34 Million
Q4 2021 Feb 09, 2022	BUY	$13.13 - $24.52 $5.3 Million - $9.9 Million	403,573 Added 118.3%	744,728 $11.1 Million
Q3 2021 Nov 12, 2021	BUY	$21.01 - $27.64 $6.71 Million - $8.83 Million	319,311 Added 1461.78%	341,155 $8.77 Million
Q1 2021 May 14, 2021	SELL	$25.79 - $39.02 $606,297 - $917,321	-23,509 Reduced 51.84%	21,844 $771,000
Q4 2020 Feb 25, 2021	BUY	$25.24 - $43.45 $1.14 Million - $1.97 Million	45,353 New	45,353 $1.15 Million

Others Institutions Holding ALLO

# of Institutions

182

Shares Held

138M

Call Options Held

76.6K

Put Options Held

36.2K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $177M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Allogene Therapeutics, Inc. Transaction History